SCD and ovarian carcinoma: Kato et al. found 44 that MI-463(a Menin‐mixed‐lineage leukemia inhibitor) induces ovarian cancer cell line death through the induction of ferroptosis, which may be due at least in part to the inhibition of SCD1 activity.